Global Pulmonary Arterial Hypertension (PAH) Market (By Drug Class, By Region, By Country): Opportunities and Forecasts (2016-2021)

1
Global Pulmonary Arterial Hypertension (PAH)
Market (By Drug Class, By Region, By Country)
Opportunities and Forecasts (2016-2021)

• By Market Segment (By Drug Class) - Endothelin
  Receptor Antagonists, Prostacyclin and
  Prostacyclin Analogs, Phosphodiesterase V
  Inhibitors, Others
• By Region-North America, Europe, APAC, Latin
  America, MEA
• By Country- USA, Canada, UK, Germany, Japan,
  Brazil, South Africa

August 2016
2
Scope of the Study Global Pulmonary Arterial
Hypertension Market
2
3
Scope of the Study Global Pulmonary Arterial
Hypertension Market
Coverage By Region
Europe
APAC
Latin America
MEA
North America
3
4
Research Methodology
Azoth Analytics has conducted quantitative as
well as qualitative research to gather market
insights such as market sizing, market
segmentation, recent trends and developments and
competitive landscape. Our team has conducted
extensive primary surveys by reaching out
industry experts across the value chain of the
Global pulmonary arterial hypertension market.
For Forecasting purpose we have accessed some of
the paid databases such as Bloomberg, Reuters,
Factiva, Hoovers etc.
Companies Contacted
Actelion Pharmacuticals, Gilead Sciences,
Pfizer, Glaxo Smithkline, United Therapeutics,
4
5
Global Pulmonary Arterial Hypertension Market
Figure 4 Global PAH Market, 2016E-2021F (USD
Billion)
Figure 1 Global PAH Market , 2011-2015 (USD
Billion)
Source Azoth Analytics Estimates
Figure 6 Global PAH Market By Drug Class Type,
By Value, 2021F (In Percentage)
Figure 5 Global PAH Market By Drug Class Type,
By Value, 2016E (In Percentage)
5
6
Global Pulmonary Arterial Hypertension Market
Figure 7 Global PAH Market By ERA, By Value,
2011-2021F (in USD Billion)
Source Azoth Analytics Estimates
Figure 8 Global PAH Market By Prostacyclin and
Prostacyclin Analogs, By Value, 2011-2021F (in
USD Billion)
6
7
Global Pulmonary Arterial Hypertension Market
Figure 9 Global PAH Market By
Phosphodiesterase V Inhibitors, By Value,
2011-2021F (in USD Million)
Source Azoth Analytics Estimates
Figure 12 North America PAH Market , 2016E-
2021F (USD Billion)
Figure 9 Global PAH Market By
Phosphodiesterase V Inhibitors, By Value,
2011-2021F (in USD Million)
7
8
Global Pulmonary Arterial Hypertension Market
Figure 18 Europe PAH Market , 2016E- 2021F (USD
Billion)
Figure 17 Europe PAH Market , 2011-2015 (USD
Billion)
Source Azoth Analytics Estimates
Figure 22 APAC PAH Market , 2011-2015 (USD
Million)
Figure 23 APAC PAH Market , 2016E - 2021F (USD
Million)
8
9
Global Pulmonary Arterial Hypertension Market
Figure 27 Latin America PAH Market , 2016E-
2021F (USD Million)
Figure 26 Latin America PAH Market , 2011-2015
(USD Million)
Source Azoth Analytics Estimates
Figure 30 MEA PAH Market , 2011-2015 (USD
Million)
Figure 31 MEA PAH Market , 2016E- 2021F (USD
Million)
9
10
Global Pulmonary Arterial Hypertension (PAH)
Market (By Drug Class, By Region, By Country)
Opportunities and Forecasts (2016-2021)  For
Details, Please Follow the Link
Below http//www.azothanalytics.com/report/heal
thcare-pharma/global-pulmonary-arterial-hypertensi
on-pah-market-by-drug-class-by-region-by-country-o
pportunities-and-forecasts-2016-2021-r58 Contact
Us
About Azoth Analytics Pvt
Ltd. Azoth Analytics creates in-depth research
reports by recording, interpreting and analyzing
information through primary and secondary
research. Our strategic market sizing and data
dredging techniques include secondary research,
interviews with key market players and industry
experts and use of industry specific statistical
tools which helps in designing and planning
effective research for our global and local
clients. We provide customized market research
reports revealing the hidden truths on different
verticals like pharmaceutical, oil and gas,
retail, automotive, real estate, logistics,
energy, healthcare, technology, FMCG, food
beverages and media sectors .
binny_at_azothanalytics.om
91 9873-4262-88
10